Study Stopped
Slow recruitment over 3 yrs (n=47). No chance to reach sample size (n=\~160).
Suprapubic Aspiration Versus Urinary Catheterization In Neonates.
SPA
A Randomized Controlled Trial: Suprapubic Aspiration Versus Urinary Catheterization in the Neonatal Intensive Care Unit.
1 other identifier
interventional
49
1 country
2
Brief Summary
Urinary tract infection (UTI) is relatively common in infants, with an occurence rate of up to 10%. Analysis of collected urine for the presence of bacteria or fungus is the only way to make a certain UTI diagnosis. Sterile collection of urine can be achieved in newborn infants by urinary catheterization (UC) where a catheter is passed through the urethra into the bladder, suprapubic aspiration (SPA) where a needle is inserted into the bladder through the abdominal wall, or 'clean catch' where urine is collected into a sterile bottle as the baby urinates during preparation for UC. The main advantage of SPA is that it bypasses the bacteria that normally resides in the urethral opening, thus minimizing the risk of contamination. Some studies have suggested that SPA is better than UC for collecting urine in a sterile fashion in the neonate due to the difficulty of doing sterile UC in small infants resulting in more contaminated samples (also called a false-positive urine culture); there is still no clear best choice. UC is commonly used in many Neonatal Intensive Care Units (NICU) as it is considered less invasive, can be done by the nursing staff, and generally has a higher chance of obtaining urine. SPA is a simple and safe alternative and, although it may be more painful than UC, it is performed more quickly. The reported success rate for SPA is variable, but is greatly increased when an ultrasound confirms urine in the bladder. The question remains: what is the best method for sterile collection of urine in neonates? In this study, the investigators will try to answer this question by collecting urine from neonates using either ultrasound guided SPA or UC and then comparing the contamination rates between these two methods. The investigators hypothesize that SPA will result in less contamination of urine samples. The investigators also hypothesize that there will be more success in obtaining an adequate urine sample (0.5 ml) by SPA, and that there will be no difference in associated complication rates between SPA and UC.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2013
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 7, 2012
CompletedFirst Posted
Study publicly available on registry
November 14, 2012
CompletedStudy Start
First participant enrolled
April 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedJanuary 22, 2020
January 1, 2020
3.1 years
November 7, 2012
January 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of contaminated urine samples per SPA and UC
For SPA samples, urine contamination will be defined as the growth of two or more micro-organisms (any number of colonies per each microorganism) or the growth of Candida species plus growth of any other microorganism. For UC samples, urine contamination will be defined as the growth of two or more micro-organisms (any number of colonies per each microorganism) or any growth \<10\^4 colony forming unit(CFU)/ml or the growth of Candida species plus growth of any other microorganism. The different cut-off used for contamination between UC and SPA samples stems from the fact that the UC procedure is not sterile in the neonatal population. Note that a bacterial load of \<10\^3 CFU/mL (e.g. 10\^1 or 10\^2 CFU/mL) does not grow in the media of either laboratory where our study samples are being cultured. Further sensitivity analyses will be performed on this outcome measure.
up to 2 years
Secondary Outcomes (5)
Success rates of obtaining urine by SPA versus UC
up to 2 years
Time to perform the respective procedures
up to 2 years
Complication rates of SPA versus UC
up to 2 years
Contamination rates of SPA versus UC (excluding clean catch urine)
up to 2 years
Number of attempts per procedure
up to 2 years
Study Arms (2)
Suprapubic Aspiration
ACTIVE COMPARATORA trained physician or neonatal nurse practitioner utilizing U/S guidance at the bedside will perform the SPA. An U/S machine is readily available for use in each NICU.
Urinary Catheterization
ACTIVE COMPARATORThe infants will have the procedure done by NICU nurses who have been trained in performing this procedure. If the randomly assigned infant passes urine spontaneously during a UC attempt after complete perineal cleansing and the urine is collected as a "clean catch" sample, then this infant will be analysed in the assigned group (intention to treat).
Interventions
Pain management will be performed as per our NICU protocols by administering 24% sucrose prior to both procedures to ensure adequate pain control. Additional or different analgesia may be used depending on the patient's specific clinical situation. We will use a chlorhexidine 0.05% with no cetrimide solution as the cleaning solution.
Pain management will be performed as per our NICU protocols by administering 24% sucrose prior to both procedures to ensure adequate pain control. Additional or different analgesia may be used depending on the patient's specific clinical situation. We will use a chlorhexidine 0.05% with no cetrimide solution as the cleaning solution.
Eligibility Criteria
You may not qualify if:
- Antenatal detection or suspicion of genitourinary anomaly including: ambiguous genitalia, hypospadias, posterior urethral valve, anal atresia, exstrophy-epispadias complex, and oligohydramnios secondary to probable genitourinary anomaly(e.g. renal agenesis, multicystic kidney disease)
- Antenatal hydrops
- Antenatally detected abdominal wall defect or abdominal masses
- Antenatally detected grossly dilated bowel loops
- Congenital abdominal skin lesion over the SPA puncture site
- All infants who are greater than 72 hours of age, who are being investigated for a possible UTI, and have been consented will be eligible for randomization
- Oliguria (\<0.5 cc/kg/hr) or anuria over the 8 hours prior to attempted urine collection
- Skin infection over the SPA puncture site
- Distension or enlargement of abdominal viscera (e.g. grossly dilated loops of bowel or massive organomegaly)
- Active Necrotizing enterocolitis (Bell stage II or more)
- Uncorrected thrombocytopenia (platelets \< 50 x 10 6) or bleeding diathesis
- Post-abdominal surgery
- Large inguinal hernia
- Current pre-existing indwelling catheter
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Children's Hospital of Eastern Ontario
Ottawa, Ontario, K1H 8L1, Canada
The Ottawa Hospital - General campus
Ottawa, Ontario, K1H 8L6, K1H 8L6, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gregory P Moore, MD
Children's Hospital of Eastern Ontario; Ottawa Hospital; University of Ottawa
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, Neonatologist
Study Record Dates
First Submitted
November 7, 2012
First Posted
November 14, 2012
Study Start
April 1, 2013
Primary Completion
May 1, 2016
Study Completion
May 1, 2016
Last Updated
January 22, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share